Broadening the Reach, Impact, and Delivery of Genetic Services (BRIDGE) Chatbot or Standard of Care Trial for Genetic Cancer Counseling, New York and Utah, 2020-2023 (ICPSR 39256)
Version Date: Feb 20, 2025 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Kimberly A. Kaphingst, University of Utah
https://doi.org/10.3886/ICPSR39256.v1
Version V1
Summary View help for Summary
The Broadening the Reach, Impact, and Delivery of Genetic Services (BRIDGE) randomized controlled trial included 3,073 eligible patients between 2020-2023. The trial examined whether chatbot and standard of care approaches are equivalent in completion of pre-test cancer genetic services and genetic testing.
Citation View help for Citation
Export Citation:
Funding View help for Funding
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Smallest Geographic Unit View help for Smallest Geographic Unit
university
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Data Collection Notes View help for Data Collection Notes
- This collection is related to Broadening the Reach, Impact, and Delivery of Genetic Services (BRIDGE) Family History Interviews, New York and Utah, 2021, ICPSR 38831. For similar study information and characteristics, please refer to both studies.
Study Purpose View help for Study Purpose
The purpose of this study is to compare patients use of chatbot or standard of care approaches for genetic cancer testing.
Study Design View help for Study Design
3,073 patients from New York State and Utah were selected from a population health registry for a randomized controlled trial. The trial was conducted at the University of Utah Health and NYU Langone Health.
From 2020-2023, patients were given counseling for pre-test hereditary cancer from either a chatbot or standard of care. Focus was on if patients had started and completed genetic cancer services, or requested for genetic cancer testing. Some sociodemographic variables such as age, gender, and urbanicity was recorded.
Sample View help for Sample
Random samples of 2,241 patients at University of Utah Health and 3,061 at NYU Langone Health were selected from a population health registry.
Time Method View help for Time Method
Universe View help for Universe
Trial participants were aged 25 to 60 years, had a primary care visit in the previous 3 years, eligible for cancer genetic evaluation, English or Spanish speaking, no prior cancer diagnosis other than non-melanoma skin cancer, no prior cancer genetic counseling or testing, and had an electronic patient portal account.
Unit(s) of Observation View help for Unit(s) of Observation
Data Type(s) View help for Data Type(s)
Mode of Data Collection View help for Mode of Data Collection
Description of Variables View help for Description of Variables
The data includes variables about participants' use of genetic cancer counseling by chatbot or standard of care approaches. There are geographic variables (state) and demographic variables (age, gender, urbanicity, and language).
Response Rates View help for Response Rates
1,629 patients from New York State and 1,444 patients from Utah participated in the study.
HideNotes
These data are freely available to data users at ICPSR member institutions. The curation and dissemination of this study are provided by the institutional members of ICPSR. How do I access ICPSR data if I am not at a member institution?